Publications

Journal Articles

  1. & Arterial Pathophysiology and Comparison of Two Devices for Pulse Wave Velocity Assessment in Elderly Men -The British Regional Heart Study. Open Heart
  2. & Active children through individual vouchers – evaluation (ACTIVE): protocol for a mixed method randomised control trial to increase physical activity levels in teenagers. BMC Public Health 18(1)
  3. & Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation 136(11), CIRCULATIONAHA.117.030583
  4. & Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open 7(9), e015363
  5. & Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis 264, 36-43.
  6. & Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovascular Disorders 17(1)
  7. & Guidelines for type 2 diabetes: keeping a finger on the pulse. The Lancet Diabetes & Endocrinology 5(6), 420
  8. & Self-reported sleep duration and napping, cardiac risk factors and markers of subclinical vascular disease: cross-sectional study in older men. BMJ Open 7(6), e016396
  9. et. al. Screening for Atrial Fibrillation. Circulation 135(19), 1851-1867.
  10. et. al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. New England Journal of Medicine 376(16), 1527-1539.
  11. & Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. BMJ Open 7(1), e013398
  12. & The association between blood pressure and lipid levels in Europe. Journal of Hypertension 34(11), 2155-2163.
  13. & Objectively measured physical activity, sedentary time and subclinical vascular disease: Cross-sectional study in older British men. Preventive Medicine 89, 194-199.
  14. & Validation of a new method for non-invasive assessment of vasomotor function. European Journal of Preventive Cardiology 23(6), 577-583.
  15. & Objectively measured physical activity and sedentary behaviour and ankle brachial index: Cross-sectional and longitudinal associations in older men. Atherosclerosis 247, 28-34.
  16. & HbA1cmeasurement and relationship to incident stroke. Diabetic Medicine 33(4), 459-462.
  17. & Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study. International Journal of Cardiology
  18. & Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?. Brain, Behavior, and Immunity
  19. et. al. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis
  20. & Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe. PLOS ONE 10(2), e0115270
  21. Halcox, J., Misra, A. Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?. Metabolic Syndrome and Related Disorders 13(1), 1-21.
  22. Halcox, J.P., Tubach, F., Sazova, O., Sweet, S., Medina, J. Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm. European Journal of Preventive Cardiology 22(2), 200-202.
  23. & Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, Obesity and Metabolism 16(11), 1165-1173.
  24. & C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovascular Disorders 14(1), 25
  25. Radke, P.W., Halvorsen, S., Jukema, J.W., Kolh, P., Annemans, L., Postma, M.J., Ardissino, D., Kristensen, S.D., Bassand, J.-P., Collet, J.-P., Morais, J., Tuñón, J., Halcox, J. Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care 16(2), 41-48.
  26. Halcox, J.P., Currie, C.J. Lipid-lowering therapy and mortality post-MI: is it just about the LDL?. Heart 100(11), 825-826.
  27. Prescott, E., Abildstrøm, S.Z., Aziz, A., Merz, N.B., Gustafsson, I., Halcox, J., Hansen, H.S., Hansen, P.R., Kastrup, J., Michelsen, M., Mygind, N.D., Ong, P., Pena, A., Rosengren, A., Sechtem, U., Søgaard, P. Improving diagnosis and treatment of women with angina pectoris and microvascular disease: The iPOWER study design and rationale. American Heart Journal 167(4), 452-458.
  28. Edwards, M.O., Watkins, W.J., Kotecha, S.J., Halcox, J.P.J., Dunstan, F.D., Henderson, A.J., Kotecha, S. Higher systolic blood pressure with normal vascular function measurements in preterm-born children. Acta Paediatrica 103(9), 904-912.
  29. Bhatti, Z.U., Finlay, A.Y., Bolton, C.E., George, L., Halcox, J.P., Jones, S.M., Ketchell, R.I., Moore, R.H., Salek, M.S. Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine. Journal of the European Academy of Dermatology and Venereology 28(10), 1344-1355.
  30. Rees, E., Coulson, R., Dunstan, F., Evans, W.D., Blundell, H.L., Luzio, S.D., Dunseath, G., Halcox, J.P., Fraser, A.G., Rees, D.A. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk. Human Reproduction 29(9), 2041-2049.
  31. Bhatti, Z.U., Salek, S.S., Bolton, C.E., George, L., Halcox, J.P., Jones, S.M., Ketchell, I.R., Moore, R.H., Sabit, R., Piguet, V., Finlay, A.Y. The development and validation of the major life changing decision profile (MLCDP). Health and Quality of Life Outcomes 11(1), 78
  32. Poole, C.D., Halcox, J.P., Jenkins-Jones, S., Carr, E.S.M., Schifflers, M.G., Ray, K.K., Currie, C.J. Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort Study. Clinical Therapeutics 35(1), 40-51.
  33. Ingram, T.E., Fraser, A.G., Bleasdale, R.A., Ellins, E.A., Margulescu, A.D., Halcox, J.P., James, P.E. Low-Dose Sodium Nitrite Attenuates Myocardial Ischemia and Vascular Ischemia-Reperfusion Injury in Human Models. Journal of the American College of Cardiology 61(25), 2534-2541.
  34. Halcox, J.P. Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters. Clinical Lipidology 8(3), 329-344.
  35. Dallongeville, J., Banegas, J.R., Tubach, F., Guallar, E., Borghi, C., Backer, G.D., Halcox, J.P.J., Massó-González, E.L., Perk, J., Sazova, O., Steg, P.G., Artalejo, F.R. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. European Journal of Preventive Cardiology 19(3), 541-550.
  36. Begg, A., Connolly, S., Halcox, J., Kaba, A., Main, L., Ray, K., Purcell, H., Williams, H., Yellon, D. Omega-3 fatty acids in cardiovascular disease: re-assessing the evidence. British Journal of Cardiology 19(2)
  37. Fabbri-Arrigoni, F.I., Clarke, L., Wang, G., Charakida, M., Ellins, E., Halliday, N., Brogan, P.A., Deanfield, J.E., Halcox, J.P., Klein, N. Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia. Pediatric Research 72(3), 299-304.
  38. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. European Heart Journal 32, 2143-2152.
  39. Achievement of lipoprotein goals among patients with metabolic syndrome at high. Int Journal of Cardiology 116, 210-214.
  40. Reiner, Ž., Catapano, A.L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M.J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P.P., Riccardi, G., Storey, R.F., Wood, D. Wytyczne ESC/EAS dotycza̧ce postêpowania w dyslipidemiach. Kardiologia Polska 69
  41. Ellins, E.A., Halcox, J.P.J. Where Are We Heading with Noninvasive Clinical Vascular Physiology? Why and How Should We Assess Endothelial Function?. Cardiology Research and Practice 1, 1-9.
  42. Halcox, J. The British Journal of Cardiology: Foreword. British Journal of Cardiology 18
  43. Zafari, A.M., Quyyumi, A.A., Halcox, J.P.J., Rajagopalan, S. The Arterial Pulse: Vascular Biology, Vascular Function Testing, and Therapies. Cardiology Research and Practice 1, 1-2.
  44. Ryabikov, A., Malyutina, S., Halcox, J., Nikitin, Y., Marmot, M., Bobak, M. Prevalence and Predictors of Carotid Wall Triple Line Pattern in a General Population Sample. Arteriosclerosis, Thrombosis, and Vascular Biology 31(7), 1682-1688.
  45. Halcox, J., Lindsay, S., Begg, A., Griffith, K., Mead, A., Barr, B. Lifestyle advice and drug therapy post-myocardial infarction: A survey of UK current practice. British Journal of Cardiology 18
  46. Halcox, J.P. Letter by Halcox Regarding Article, "OMEGA, A Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction". Circulation 124(1), e21-e21.
  47. Godfrey, E., Halcox, J.P. How do we approach low high-density lipoprotein cholesterol in 2011?. European Cardiology 7
  48. Arrigoni, F.I., Matarin, M., Thompson, P.J., Michaelides, M., McClements, M.E., Redmond, E., Clarke, L., Ellins, E., Mohamed, S., Pavord, I., Hunt, D.M., Moore, A.T., Halcox, J., Sisodiya, S.M. Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy. European Journal of Human Genetics 19(2), 131-137.
  49. Guallar, E., Banegas, J.R., Blasco-Colmenares, E., Jiménez, F.J., Dallongeville, J., Halcox, J.P., Borghi, C., Massá-González, E.L., Tafalla, M., Perk, J., De Backer, G., Steg, P.G., Rodríguez-Artalejo, F. Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. BMC Public Health 11(1), 704
  50. Reiner, Z., Catapano, A.L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M.J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P.P., Riccardi, G., Storey, R.F., Wood, D. ESC/EAS Kilavuzlari: Dislipidemilerin tedavisi. Turk Kardiyoloji Dernegi Arsivi 39
  51. Catapano, A.L., Reiner, T., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M.J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R.F., Wood, D. ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis 217(1), 3-46.
  52. Catapano, A.L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M.J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R.F., Wood, D. ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis 217, 1-44.
  53. Arrigoni, F.I., Matarin, M., Thompson, P.J., Michaelides, M., McClements, M.E., Redmond, E., Clarke, L., Ellins, E., Mohamed, S., Pavord, I., Klein, N., Hunt, D.M., Moore, A.T., Halcox, J., Sisodiya, S.M. Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy. European Journal of Human Genetics 19(9), 1018-1018.
  54. Bundhoo, S.S., Anderson, R.A., Sagan, E., Dada, J., Harris, R., Halcox, J.P., Lang, D., James, P.E. Direct Vasoactive Properties of Thienopyridine-Derived Nitrosothiols. Journal of Cardiovascular Pharmacology 58(5), 550-558.
  55. Lee, W.P., Datta, B.N., Ong, B.B., Rees, A., Halcox, J. Defining the Role of Lipoprotein Apheresis in the Management of Familial Hypercholesterolemia. American Journal Cardiovascular Drugs 11(6), 363-370.
  56. Halcox, J. What are omega-3 fatty acids and what is their role in cardiovascular health?. Primary Care Cardiovascular Journal 3
  57. Corr, U., Carré, F., Heuschmann, P., Hoffmann, U., Verschuren, M., Halcox, J., Giannuzzi, P., Saner, H., Wood, D., Piepoli, M.F., Benzer, W., Bjarnason-Wehrens, B., Dendale, P., Gaita, D., McGee, H., Mendes, M., Niebauer, J., Zwisler, A.-D.O., Schmid, J.-P. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. European Heart Journal 31(16), 1967-1974.
  58. Rodríguez-Artalejo, F., Guallar, E., Borghi, C., Dallongeville, J., De Backer, G., Halcox, J.P., Hernndez-Vecino, R., Jiménez, F.J., Massá-Gonzlez, E.L., Perk, J., Steg, P.G., Banegas, J.R. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health 10(1), 382
  59. Lindsay, A.C., Halcox, J.P. Niacin Compared with Ezetimibe. New England Journal of Medicine 362(11), 1046-1048.
  60. Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., James, S., Knuuti, J., Lopez-Sendon, J., Marco, J., Menicanti, L., Ostojic, M., Piepoli, M.F., Pirlet, C., Pomar, J.L., Reifart, N., Ribichini, F.L., Schalij, M.J., Sergeant, P., Serruys, P.W., Silber, S., Sousa Uva, M., Taggart, D., Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., Popescu, B.A., Reiner, Z., Sechtem, U., Sirnes, P.A., Tendera, M., Vardas, P.E., Widimsky, P., Alfieri, O., Dunning, J., Elia, S., Kappetein, P., Lockowandt, U., Sarris, G., Vouhe, P., Von Segesser, L., Agewall, S., Aladashvili, A., Alexopoulos, D., Antunes, M.J., Atalar, E., Brutel De La Riviere, A., Doganov, A., Eha, J., Fajadet, J., Ferreira, R., Garot, J., Halcox, J., Hasin, Y., Janssens, S., Kervinen, K., Laufer, G., Legrand, V., Nashef, S.A.M., Neumann, F.-J., Niemela, K., Nihoyannopoulos, P., Noc, M., Piek, J.J., Pirk, J., Rozenman, Y., Sabate, M., Starc, R., Thielmann, M., Wheatley, D.J., Windecker, S., Zembala, M. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31(20), 2501-2555.
  61. Charakida, M., Donald, A.E., Leary, S., Halcox, J.P., Turner, M.W., Johnson, M., Loukogeorgakis, S.P., Okorie, M.I., Smith, G.D., Deanfield, J.E., Klein, N.J. Endothelial response to childhood infection: The role of mannose-binding lectin (MBL). Atherosclerosis 208(1), 217-221.
  62. Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal. EHJ 33, 1502-1510.
  63. Endothelial Function Predicts Progression of Carotid Intima-Media Thickness. Circulation 119, 1005-1012.
  64. Freeman, P.M., Halcox, J.P.J. Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction. Heart 95(16), 1301-1302.
  65. Charakida, M., Loukogeorgakis, S.P., Okorie, M.I., Masi, S., Halcox, J.P., Deanfield, J.E., Klein, N.J. Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy. Antiviral Therapy 14(8), 1075-1079.
  66. Endothelial dysfunction and Cytomegalovirus. Circulation 117, 2657-2661.
  67. Methodological Approaches to Optimize Reproducibility and Power in Clinical Studies of Flow-Mediated Dilation. JACC 50(21), 1959-1964.
  68. Ellins, E., Shamaei-Tousi, A., Steptoe, A., Donald, A., Omeagher, S., Halcox, J., Henderson, B. The relationship between carotid stiffness and circulating levels of heat shock protein 60 in middle-aged men and women. Journal of Hypertension 26(12), 2389-2392.
  69. Steptoe, A., Halcox, J. The authors' reply. Heart 94
  70. Agrawal, V., Ellins, E., Donald, A., Minhas, S., Halcox, J., Ralph, D.J. ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Systemic Vascular Endothelial Dysfunction in Peyronie's Disease. The Journal of Sexual Medicine 5(11), 2688-2693.
  71. Singh-Manoux, A., Britton, A., Kivimaki, M., Guéguen, A., Halcox, J., Marmot, M. Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: Evidence from the Whitehall II study. Atherosclerosis 197(2), 541-548.
  72. Clarke, L.A., Shah, V., Arrigoni, F., Eleftheriou, D., Hong, Y., Halcox, J., Klein, N., Brogan, P.A. Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction. Journal of Thrombosis and Haemostasis 6(6), 1025-1032.
  73. Taylor, J.S.W., Halcox, J.P.J. PDE5 inhibitors and pulmonary hypertension. Current Sexual Health Reports 5(4), 171-178.
  74. Chen, S.S.M., Donald, A.E., Storry, C., Halcox, J.P., Bonhoeffer, P., Deanfield, J.E. Impact of aortic stenting on peripheral vascular function and daytime systolic blood pressure in adult coarctation. Heart 94(7), 919-924.
  75. Kivimáki, M., Lawlor, D.A., Smith, G.D., Kumari, M., Donald, A., Britton, A., Casas, J.P., Shah, T., Brunner, E., Timpson, N.J., Halcox, J.P.J., Miller, M.A., Humphries, S.E., Deanfield, J., Marmot, M.G., Hingorani, A.D. Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study. PLoS ONE 3(8), e3013
  76. Halcox, J.P.J. Dilatation in the femoral vascular bed does not cause retrograde relaxation of the iliac artery in the anaesthetized pig. Acta Physiologica 194(3), 175-175.
  77. Ellins, E., Halcox, J., Donald, A., Field, B., Brydon, L., Deanfield, J., Steptoe, A. Arterial stiffness and inflammatory response to psychophysiological stress. Brain, Behavior, and Immunity 22(6), 941-948.
  78. Shamaei-Tousi, A., Halcox, J.P., Henderson, B. Stressing the obvious? Cell stress and cell stress proteins in cardiovascular disease. Cardiovascular Research 74(1), 19-28.
  79. Deanfield, J.E., Halcox, J.P., Rabelink, T.J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 115
  80. Halcox, J.P.J., Nour, K.R.A., Zalos, G., Quyyumi, A.A. Endogenous Endothelin in Human Coronary Vascular Function: Differential Contribution of Endothelin Receptor Types A and B. Hypertension 49(5), 1134-1141.
  81. Charakida, M., Deanfield, J.E., Halcox, J.P. Childhood origins of arterial disease. Current Opinion in Pediatrics 19(5), 538-545.
  82. Ostberg, J.E., Storry, C., Donald, A.E., Attar, M.J.H., Halcox, J.P.J., Conway, G.S. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clinical Endocrinology 66(0), 070302041622001-???.
  83. Charakida, M., Deanfield, J.E., Halcox, J.P.J. The role of nitric oxide in early atherosclerosis. European Journal of Clinical Pharmacology 62(S1), 69-78.
  84. Bastiaenen, R., Halcox, J. The imaging of coronary artery disease. Medicine 34(9), 373-376.
  85. Donald, A.E., Charakida, M., Cole, T.J., Friberg, P., Chowienczyk, P.J., Millasseau, S.C., Deanfield, J.E., Halcox, J.P. Non-Invasive Assessment of Endothelial Function. Journal of the American College of Cardiology 48(9), 1846-1850.
  86. Page, S.P., Halcox, J.P.J. Management of hypertension. Medicine 34(8), 290-295.
  87. Ostberg, J.E., Donald, A.E., Halcox, J.P.J., Storry, C., McCarthy, C., Conway, G.S. Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction. The Journal of Clinical Endocrinology & Metabolism 90(9), 5161-5166.
  88. Lindsay, A.C., Halcox, J.P.J. Stem cells as future therapy in cardiology. Hospital Medicine 66
  89. Brunner, H., Cockcroft, J.R., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., Kiowski, W., Lüscher, T.F., Mancia, G., Natali, A., Oliver, J.J., Pessina, A.C., Rizzoni, D., Rossi, G.P., Salvetti, A., Spieker, L.E., Taddei, S., Webb, D.J. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*. Journal of Hypertension 23(2), 233-246.
  90. Deanfield, J., Donald, A., Ferri, C., Giannattasio, C., Halcox, J., Halligan, S., Lerman, A., Mancia, G., Oliver, J.J., Pessina, A.C., Rizzoni, D., Rossi, G.P., Salvetti, A., Schiffrin, E.L., Taddei, S., Webb, D.J. Endothelial function and dysfunction. Part I. Journal of Hypertension 23(1), 7-17.
  91. Charakida, M., Donald, A.E., Terese, M., Leary, S., Halcox, J.P., Ness, A., Smith, G.D., Golding, J., Friberg, P., Klein, N.J., Deanfield, J.E. Endothelial Dysfunction in Childhood Infection. Circulation 111(13), 1660-1665.
  92. Charakida, M., Donald, A.E., Green, H., Storry, C., Clapson, M., Caslake, M., Dunn, D.T., Halcox, J.P., Gibb, D.M., Klein, N.J., Deanfield, J.E. Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy. Circulation 112(1), 103-109.
  93. Halcox, J.P., Deanfield, J., Shamaei-Tousi, A., Henderson, B., Steptoe, A., Coates, A.R., Singhal, A., Lucas, A. Circulating human heat shock protein 60 in the blood of healthy teenagers: a novel determinant of endothelial dysfunction and early vascular injury?. Arteriosclerosis, thrombosis, and vascular biology. 25
  94. Halcox, J.P.J., Deanfield, J.E. Childhood origins of endothelial dysfunction. Heart 91(10), 1272-1274.
  95. Ostberg, J.E., Brookes, J.A.S., McCarthy, C., Halcox, J., Conway, G.S. A Comparison of Echocardiography and Magnetic Resonance Imaging in Cardiovascular Screening of Adults with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism 89(12), 5966-5971.
  96. Halcox, J.P.J., Deanfield, J.E. Endothelial cell function testing: how does the method help us in evaluating vascular status?. Acta Paediatrica 93(0), 48-54.
  97. Halcox, J.P.J., Deanfield, J.E. Beyond the laboratory: Clinical implications for statin pleiotropy. Circulation 109
  98. Zhu, J., Quyyumi, A.A., Wu, H., Csako, G., Rott, D., Zalles-Ganley, A., Ogunmakinwa, J., Halcox, J., Epstein, S.E. Increased Serum Levels of Heat Shock Protein 70 Are Associated With Low Risk of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23(6), 1055-1059.
  99. Hill, J.M., Zalos, G., Halcox, J.P.J., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., Finkel, T. Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. New England Journal of Medicine 348(7), 593-600.
  100. Halcox, J.P.J., Nour, K.R.A, Zalos, G., Mincemoyer, R., Waclawiw, M.A., Rivera, C.E., Willie, G., Ellahham, S., Quyyumi, A.A. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. Journal of the American College of Cardiology 40(7), 1232-1240.
  101. Halcox, J.P.J., Schenke, W.H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M.A., Nour, K.R.A., Quyyumi, A.A. Prognostic Value of Coronary Vascular Endothelial Dysfunction. Circulation 106(6), 653-658.
  102. Prasad, A., Zhu, J., Halcox, J.P.J., Waclawiw, M.A., Epstein, S.E., Quyyumi, A.A. Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction. Circulation 106(2), 184-190.
  103. Halcox, J.P.J., Nour, K.R.A., Zalos, G., Quyyumi, A.A. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ETA receptor blockade. Circulation Research 89
  104. Halcox, J.P.J., Quyyumi, A.A. Coronary vascular endothelial function and myocardial ischemia: why should we worry about endothelial dysfunction?. Coronary Artery Disease 12(6), 475-484.
  105. Halcox, J.P.J., Narayanan, S., Cramer-Joyce, L., Mincemoyer, R., Quyyumi, A.A. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. American Journal of Physiology - Heart and Circulatory Physiology 280
  106. McDermott, D.H., Halcox, J.P.J., Schenke, W.H., Waclawiw, M.A., Merrell, M.N., Epstein, N., Quyyumi, A.A., Murphy, P.M. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circulation Research 89
  107. Zhu, J., Quyyumi, A.A., Rott, D., Csako, G., Wu, H., Halcox, J., Epstein, S.E. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: Evidence for an autoimmune component of atherogenesis. Circulation 103
  108. Prasad, A., Halcox, J.P.J., Waclawiw, M.A., Quyyumi, A.A. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis. Journal of the American College of Cardiology 38(4), 1089-1095.
  109. & Acute endothelin type a receptor antagonism improves human coronary vascular function. Heart 83
  110. Non-surgical chop cures right ventricular outflow obstruction. Heart 81

Books

  1. Halcox, J.P.J. Primer on the Autonomic Nervous System.
  2. Charakida, M., Halcox, J.P., Loukogeorgakis, S.P., Deanfield, J.E. Paediatric Cardiology.
  3. Halcox, J.P., Deanfield, J.E. Endothelial Dysfunctions in Vascular Disease.